WEST PHARM.SVCS DL-,25/ US9553061055 /
| 2024-11-07 8:03:35 AM | Chg. +1.50 | Volume | Bid4:09:19 PM | Ask4:09:19 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 304.00EUR | +0.50% | 0 Turnover: 0.00 |
302.20Bid Size: 75 | 304.30Ask Size: 75 | 22.13 bill.EUR | - | - |
Assets
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 669 | 711.7000 | 705.8000 | 721 | 778.3000 | ||||||
| Intangible Assets | 50.6000 | 48.3000 | 42 | 37.6000 | 23.3000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | 1,011.6000 | 1,021.4000 | 1,074.8000 | ||||||
| Inventories | 162.2000 | 176.9000 | 181.5000 | 181.1000 | 199.3000 | ||||||
| Accounts Receivable | 175 | 185.7000 | 179 | 181.4000 | 200.5000 | ||||||
| Cash and Cash Equivalents | 161.9000 | 230 | 255.3000 | 274.6000 | 203 | ||||||
| Current Assets | 557.3000 | 650.7000 | 659.3000 | 673.7000 | 641.9000 | ||||||
| Total Assets | 1,564 | 1,671.6000 | 1,670.9000 | 1,695.1000 | 1,716.7000 | ||||||
Liabilities
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 102.9000 | 108 | 103.1000 | 119.8000 | 122 | ||||||
| Long-term debt | - | - | 309.5000 | 228.9000 | 226.2000 | ||||||
| Liabilities to Banks | 32.7000 | 2.2000 | 27.2000 | 69.3000 | 2.4000 | ||||||
| Provisions | 28.6000 | 26.7000 | 30.6000 | 25.2000 | 13.7000 | ||||||
| Liabilities | 835.1000 | 765.2000 | 714 | 671.2000 | 599.2000 | ||||||
| Share Capital | 17.2000 | 17.6000 | 17.8000 | 18.1000 | 18.4000 | ||||||
| Total Equity | 728.9000 | 906.4000 | 956.9000 | 1,023.9000 | 1,117.5000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 1,564 | 1,671.6000 | 1,670.9000 | 1,695.1000 | 1,716.7000 | ||||||
Income Statement
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,266.4000 | 1,368.4000 | 1,368.4000 | 1,399.8000 | 1,509.1000 | ||||||
| Depreciation (total) | - | - | 81 | 86.1000 | - | ||||||
| Operating Result | 135.1000 | 162.4000 | 162.4000 | 128.6000 | 196.8000 | ||||||
| Interest Income | -14.9000 | -15.1000 | 17 | 14.1000 | 8.1000 | ||||||
| Income Before Taxes | 108.6000 | 147.1000 | 147.1000 | 116.1000 | 189.8000 | ||||||
| Income Taxes | 32.7000 | 40.2000 | 40.2000 | 26.3000 | 54.4000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 80.7000 | 112.3000 | 112.3000 | 95.6000 | 143.6000 | ||||||
Per Share
Cash Flow
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 187.4000 | 220.5000 | 220.5000 | 212.4000 | 219.4000 | ||||||
| Cash Flow from Investing Activities | -116 | -149.9000 | -149.9000 | -129.5000 | -175.8000 | ||||||
| Cash Flow from Financing | -3.4000 | -5.1000 | -5.1000 | -41.5000 | -113.9000 | ||||||
| Decrease / Increase in Cash | 70.1000 | 68.1000 | 68.1000 | 19.3000 | -71.6000 | ||||||
| Employees | 6,700 | 6,900 | 7,000 | 7,100 | 7,300 | ||||||
